Spending power
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Key facts
Counted staff
86
self-reported 51–200 band
Founded
1971
55 years
Legal entities
None matched
Office countries
1
1 address
Funding rounds
1
Post IPO equity · Aug 2024 · US$ 6.5M
Company type
Public Company
self-reported
Description
"Delivering emergency medical solutions dedicated to improving patient outcomes"
Medical Developments International (MDI) is one of Australia’s leading specialised healthcare companies. With an industry leading range of products in the areas of pain management, asthma and resuscitation, plus veterinary equipment, MDI has supplied healthcare professionals and patients innovative solutions since 1971.
MDI is a publicly listed company on the Australian Stock Exchange (ASX) with both its head office and state of the art manufacturing facilities located in Victoria, Australia.
MDI manufacture the innovative pain relief product, Penthrox® that has been widely adopted by organisations throughout Australia.
MDI has a proud history in human and veterinary medicine, throughout Australia as well as internationally. For over 30 years MDI's key products have helped healthcare professionals achieve better health outcomes for their patients
MDI is compliant with Good Manufacturing Practices as well as ISO 13485 for the manufacture of several of its products (including both pharmaceutical and medical products). Several MDI products are also CE marked, enabling them to be sold into the European Community.
Specialties
All 6 specialties
- Pain Relief / Analgesia
- Asthma and COPD Management
- Oxygen Delivery
- Carbon Dioxode Absorbers
- Veterinary Anaesthetic Machines
- Green Whistle
Locations
Country footprint
Show as table · Offices in 1 country
| Countries | 1 |
|---|---|
| Primary country | AU |
All codes: AU
Addresses
- AU4 Caribbean Drive; Scoresby; Melbourne, Victoria 3179Primary
Grid intelligence Members
Funding
Last round · 26 August 2024US$ 6.5MPost IPO equity
Rounds1
Round typePost IPO equity · secondary transaction
Amount (USD)6,500,000
Stage rank6
Investors named0
Since last round1 yr 4 mo
Funding
Show as table · 1 funding round
| Rounds | 1 |
|---|---|
| Axis | 1971 to 2026 |
| Post IPO equity · 26 Aug 2024 | US$ 6.5M |
Dated rounds only. The axis ends at the date this profile was last observed, not at today.
Signals & hiring
Hiring, headcount and registry-change signals, streamed to members.
Latest signal
Hiring activity
Headcount trend
Financials
Registry-filed capital and financial indicators, standardised by TheGrid.
Paid-up capital
Fiscal period
Registered charges
Revenue
Profit / loss
People & contacts
4 employee profiles on record · names withheld.
Names and titles are intentionally absent from this page. The source relation carries no consent record across the privacy regimes this directory spans, so it is never requested and never stored. Search engines see exactly what you see here.
Counts only. No names are stored here, and none are served.
FAQ
How many people work at Medical Developments International (MDI)?
The record holds 86 counted staff profiles at January 2026, inside the self-reported 51–200 band.
Where does Medical Developments International (MDI) have offices?
One address on record, Australia only. Primary: 4 Caribbean Drive, Scoresby, Melbourne, Victoria 3179.
Has Medical Developments International (MDI) raised funding?
One round. Latest 26 August 2024: post IPO equity, US$6,500,000.
What does Medical Developments International (MDI) list as its specialties?
Six tags on the brand's own list, among them Pain Relief / Analgesia, Asthma and COPD Management and Oxygen Delivery.
Which companies are listed alongside Medical Developments International (MDI)?
13 profiles list Medical Developments International (MDI) as a peer — 89th percentile in Pharmaceutical Manufacturing. It lists ten peers of its own.